AIDA Pharmaceuticals Inc logo

AIDA Pharmaceuticals Inc

AIDA · OTC · Health Technology, Pharmaceuticals: Other · Founded 2002

AiDa Pharmaceuticals, Inc. engages in the development, production, and distribution of pharmaceutical products. It offers Etimicin Sulfate, an antibiotic, which treats respiratory infection, kidney and urinogenital infection, soft skin tissue infection, and trauma and operations preventive uses.

Current Price
$0.00
Market Cap
$8K
Return Since Last Split
-100%
Last Split
Nov 30, 2005
Total Splits
1
Cumulative Multiple
1.25×

What If You Bought AIDA Earlier?

Investment
Purchase Date (Before Split)
Worth Today
$0
125 shares · 1×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Nov 30, 2005$0.145-for-41.25×1.25×

AIDA Pharmaceuticals Inc Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

AIDA Pharmaceuticals Inc's latest record in the split calendar is a 5-for-4 forward split effective 2005-11-30.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.